SGLT2 Inhibitors vs DPP-4 Inhibitors

Comparing two oral medication classes: mechanism differences, typical effects, and considerations. This page is part of the Diabetes Education hub on Evidence Before Claims. Content is for educational purposes only and is reviewed against peer-reviewed studies, FDA labeling, and current clinical guidelines. It does not provide diagnosis, treatment, or individualized medical adv

Reviewed by Sarah Chen, MD (illustrative reviewer) — MD, Internal Medicine. Last reviewed: May 2026. Educational content only; not medical advice.

Related topics on Evidence Before Claims